Laboratoire X.O.

Laboratoire X.O. is a French pharmaceutical company specializing in the acquisition, management, and revitalization of mature and niche medicinal brands. Founded in 2015, the company focuses on ensuring the continued availability of essential medicines across various therapeutic areas, including pain management, anesthesia, psychiatry, and cardiology. By acquiring established products from large pharmaceutical groups like Sanofi and AstraZeneca, Laboratoire X.O. optimizes their lifecycle and distribution. The company operates primarily in the European market and maintains a portfolio of over 20 brands. Its business model centers on operational excellence and strategic acquisitions to provide healthcare professionals and patients with reliable access to proven therapies.